Interventional Cardiology

This cardiac subspecialty uses minimally invasive, catheter-based technologies in a cath lab to diagnose and treat coronary artery disease (CAD). The main focus in on percutaneous coronary interventions (PCI) to revascularize patients with CAD that is causing blockages resulting in ischemia or myocardial infarction. PCI mainly consists of angioplasty and implanting stents. Interventional cardiology has greatly expanded in scope over recent years to include a number of transcatheter structural heart interventions.

FDA clears TAVR guidewire built with BASILICA in mind
The Telltale system was designed to assist cardiologists when BASILICA is required prior to TAVR.
New technique could help when cardiologists repair 2 leaky heart valves at once
Performing M-TEER and T-TEER on the same patient using a single guide catheter appears to be both safe and effective. Researchers shared their experience with this approach in Circulation: Cardiovascular Interventions.
‘Strongest growth in over a decade’: Heart tech helps Medtronic beat earnings expectations
The company's PFA and TAVR technologies both played key roles in the successful second quarter. In addition, Medtronic expects its place in the renal denervation market to make a major impact going forward.
Did Boston Scientific pull the plug too early on TAVR devices? Cardiologists weigh in
Boston Scientific stopped selling its Acurate TAVR systems after they underperformed in a few key trials and failed to gain FDA approval. Was it the right call?
New physician Medicare payments for the Agent drug-coated balloon set for 2027
Boston Scientific said two category III CPT codes are set to become permanent category I codes for physician payments starting Jan. 1, 2027.

Skip the aspirin? New study suggests prasugrel alone a safe option for CAD patients after PCI

One key detail is that no stent thrombosis events were reported among the study's 201 participants.

Surgeons revive donor heart after death, complete successful transplant

The transplant, performed at UC San Diego Health, was part of an ongoing clinical trial.

When Fear Goes Viral - What to Say to a Frightened Patient

SCAI’s president explains the key points she shares when reassuring patients who are reluctant to present for care.

IVL for calcified lesions: Where the technology stands now and where it's headed

In a new analysis, researchers highlighted IVL’s potential for helping with the treatment of coronary artery disease.

Philips to acquire interventional device firm Intact Vascular for more than $275M

Around since 2011 and based in Wayne, Pennsylvania, the company specializes in treating peripheral artery disease.

Veterans experience worse PCI outcomes at community hospitals than VA facilities

There was a 33% increase in a patient’s hazard for mortality if they received care at a community hospital.

In-hospital bleeding, 30-day mortality higher among women undergoing TAVI

The study tracked nearly 700 patients who underwent TAVI at one of two facilities in Melbourne, Australia, over a ten-year period.

'A missed opportunity': Statin use low among patients with peripheral artery disease

Researchers tracked statin use among patients with peripheral artery disease, cerebrovascular disease and coronary heart disease.

Interventional Cardiology

FDA clears TAVR guidewire built with BASILICA in mind

New technique could help when cardiologists repair 2 leaky heart valves at once

‘Strongest growth in over a decade’: Heart tech helps Medtronic beat earnings expectations

Did Boston Scientific pull the plug too early on TAVR devices? Cardiologists weigh in

New physician Medicare payments for the Agent drug-coated balloon set for 2027